Dashboard
Manage Tickers

CVKD


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/17/2025 21:06:24

cadrenal-acquires-assets-of-exithera-pharma-in-15m-milestone-linked-deal-adds-royalty-pathway-for-future-global-sales
Cadrenal Acquires Assets Of eXIthera Pharm...
09/15/2025 12:04:31

Acquisition significantly enhances the Company's pipeline by adding novel assets in acute and chronic anticoagulation setti...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/10/2025 21:06:05

cadrenal-therapeutics-q2-eps-187-misses-160-estimate
Cadrenal Therapeutics Q2 EPS $(1.87) Misse...
08/11/2025 12:12:41

Cadrenal Therapeutics (NASDAQ:CVKD) reported quarterly losses of $(1.87) per share which missed the analyst consensus estimate ...

cadrenal-therapeutics-announced-trial-initiation-plans-for-tecarfarin-for-end-stage-kidney-disease-patients-who-are-transitioning-to-dialysis-enrollment-is-planned-to-begin-later-this-year-and-will-include-patients-with-and-without-atrial-fibrillation
Cadrenal Therapeutics Announced Trial Init...
08/05/2025 10:07:26

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/15/2025 12:07:58

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
07/14/2025 12:08:12

cadrenal-therapeutics-highlights-tecarfarin-as-safer-anticoagulant-alternative-for-high-risk-lvad-patients
Cadrenal Therapeutics Highlights Tecarfari...
06/12/2025 12:18:31

LVAD patients face a high risk of bleeding events associated with oral anticoagulation alongside increased risk of cardiovascul...

hc-wainwright--co-reiterates-buy-on-cadrenal-therapeutics-maintains-32-price-target
HC Wainwright & Co. Reiterates Buy on Cadr...
05/16/2025 10:47:21

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cadrenal Therapeutics (NASDAQ:CVKD) with a Buy and maintains $32...

cadrenal-therapeutics-announces-manufacturing-and-supply-chain-milestones-for-tecarfarin-oral-vka-anticoagulant-designed-to-address-unmet-needs-in-anticoagulation-therapy
Cadrenal Therapeutics Announces Manufactur...
05/15/2025 11:35:10

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing therapeutics for patients with cardiovascular...

cadrenal-therapeutics-q1-eps-209-misses-125-estimate
Cadrenal Therapeutics Q1 EPS $(2.09) Misse...
05/08/2025 12:13:02

Cadrenal Therapeutics (NASDAQ:CVKD) reported quarterly losses of $(2.09) per share which missed the analyst consensus estimate ...

cadrenal-therapeutics-fy-2024-gaap-eps-873-misses-759-estimate
Cadrenal Therapeutics FY 2024 GAAP EPS $(8...
03/13/2025 20:21:26

Cadrenal Therapeutics (NASDAQ:CVKD) reported quarterly losses of $(8.73) per share which missed the analyst consensus estimate ...

Core News & Articles
Cadrenal Therapeutics Announces Collaborat...
03/04/2025 13:06:06

Strengthens the Potential for Improved Patient Outcomes through Improvements in the Quality of Anticoagulation, Enhancing Hemoc...

cadrenal-therapeutics-will-present-at-the-2025-bio-ceo--investor-conference-taking-place-at-the-new-york-marriott-marquis-on-february-10-11-2025
Cadrenal Therapeutics Will Present At The ...
02/05/2025 14:06:13

cadrenal-therapeutics-looks-ahead-to-2025-and-initiation-of-pivotal-phase-3-clinical-trial-for-tecarfarin-in-left-ventricular-assist-devices
Cadrenal Therapeutics Looks Ahead To 2025 ...
12/31/2024 13:10:36

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
12/13/2024 21:06:04

hc-wainwright--co-maintains-buy-on-cadrenal-therapeutics-adjusts-price-target-to-32-1-15-reverse-stock-split
HC Wainwright & Co. Maintains Buy on Cadre...
11/11/2024 17:57:48

HC Wainwright & Co. analyst Joseph Pantginis maintains Cadrenal Therapeutics (NASDAQ:CVKD) with a Buy, adjusts target to $3...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
11/04/2024 16:40:00

cadrenal-therapeutics-raises-51m-through-atm-facility-selling-391243-shares-at-an-average-price-of-1315-per-share-total-shares-outstanding-now-1496771-with-cash-balance-at-74m
Cadrenal Therapeutics Raises $5.1M Through...
10/24/2024 13:02:41

why-champions-oncology-shares-are-trading-higher-by-over-13-here-are-20-stocks-moving-premarket
Why Champions Oncology Shares Are Trading ...
09/12/2024 09:46:55

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION